Prevalence of arterial and venous thromboembolic events in diabetic patients with and without the metabolic syndrome: A cross sectional study

被引:6
作者
Dentali, F. [1 ]
Squizzato, A. [1 ]
Caprioli, M. [1 ]
Fiore, V. [1 ]
Bernasconi, M. [2 ]
Paganini, E. [2 ]
Ageno, W. [1 ]
Venco, A. [1 ]
Grandi, A. M. [1 ]
机构
[1] Univ Insubria, Dept Clin Med, I-21100 Varese, Italy
[2] Gen Hosp, Dept Clin Med, Cittiglio, Italy
关键词
CARDIOVASCULAR RISK-FACTORS; DISEASE; FIBRINOGEN;
D O I
10.1016/j.thromres.2010.12.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Metabolic syndrome (MS) is associated with an increased risk of cardiovascular events. Recent studies have found a higher prevalence of the MS in patients with idiopathic venous thromboembolic events (VTE) compared to controls suggesting a role of the MS in the pathogenesis of VTE. The presence of MS was shown to further increase the risk of arterial cardiovascular diseases (CVD) in diabetic patients. Conversely, there are no studies that have compared the risk of VTE in diabetic patients with and without the MS. Methods: A cross sectional study comparing the prevalence of arterial cardiovascular events and VTE in diabetic patients with and without the MS was conducted. Results: Nine hundred and fifty three patients were included in the study; 85.7% of patients had MS. Patients with the MS had an increased prevalence of CVD as compared with those without (23.4% vs. 11.8%) and the MS was an independent predictor of CVD in diabetic patients (OR 3.16, 95% CI 1.78, 5.59) after multiple logistic regression analysis. The prevalence of VTE was higher in patients with the MS in comparison to patients without the MS, but this association was not statistically significant (3,43% vs 1.47%; OR 2.38, 95% CI 0.56, 10.10%). Conclusion: Our study confirms the role of MS as an adjunctive cardiovascular risk factor in patients with diabetes. There is insufficient evidence to evaluate the role of the as an adjunctive risk factor for VTE in these patients. Further studies are necessary to confirm or refute these preliminary findings. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:299 / 302
页数:4
相关论文
共 26 条
[1]   The metabolic syndrome and the risk of venous thrombosis: a case-control study [J].
Ageno, W. ;
Prandoni, P. ;
Romualdi, E. ;
Ghirarduzzi, A. ;
Dentali, F. ;
Pesavento, R. ;
Crowther, M. ;
Venco, A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (09) :1914-1918
[2]   Cardiovascular risk factors and venous thromboembolism - A meta-analysis [J].
Ageno, Walter ;
Becattini, Cecilia ;
Brighton, Timothy ;
Selby, Rita ;
Kamphuisen, Pieter W. .
CIRCULATION, 2008, 117 (01) :93-102
[3]   Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J].
Alberti, K. G. M. M. ;
Eckel, Robert H. ;
Grundy, Scott M. ;
Zimmet, Paul Z. ;
Cleeman, James I. ;
Donato, Karen A. ;
Fruchart, Jean-Charles ;
James, W. Philip T. ;
Loria, Catherine M. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2009, 120 (16) :1640-1645
[4]   NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older [J].
Alexander, CM ;
Landsman, PB ;
Teutsch, SM ;
Haffner, SM .
DIABETES, 2003, 52 (05) :1210-1214
[5]  
ASHWELL M, 1982, INT J OBESITY, V6, P143
[6]   Venous thromboembolism - a manifestation of the metabolic syndrome [J].
Ay, Cihan ;
Tengler, Theres ;
Vormittag, Rainer ;
Simanek, Ralph ;
Dorda, Wolfgang ;
Vukovich, Thomas ;
Pabinger, Ingrid .
HAEMATOLOGICA, 2007, 92 (03) :374-380
[7]   The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study [J].
Bonora, E ;
Targher, G ;
Formentini, G ;
Calcaterra, F ;
Lombardi, S ;
Marini, F ;
Zenari, L ;
Saggiani, F ;
Poli, M ;
Perbellini, S ;
Raffaelli, A ;
Gemma, L ;
Santi, L ;
Bonadonna, RC ;
Muggeo, M .
DIABETIC MEDICINE, 2004, 21 (01) :52-58
[8]   Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromso study [J].
Borch, K. H. ;
Braekkan, S. K. ;
Mathiesen, E. B. ;
Njolstad, I. ;
Wilsgaard, T. ;
Stormer, J. ;
Hansen, J. -B .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (05) :739-745
[9]  
Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855
[10]   Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults - The ARIC study [J].
Duncan, BB ;
Schmidt, MI ;
Chambless, LE ;
Folsom, AR ;
Carpenter, M ;
Heiss, G .
OBESITY RESEARCH, 2000, 8 (04) :279-286